• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

RASSEGNE - Reviews

Volume:

Biochimica Clinica 2013; 37(5) 357-364

Pubblicato on-line:

DOI:

Scarica in PDF:
Autenticazione richiesta

Razionale e prospettive della determinazione delle catene leggere libere del siero nelle patologie infiammatorie croniche

AUTORI

Umberto Basile1, Michele Mussap2
1Dipartimento Medicina di Laboratorio, Analisi Immunologiche, Università Cattolica del Sacro Cuore, Policlinico Agostino Gemelli, Roma
2Laboratorio Analisi, IRCCS San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova

ABSTRACT

Rationale and prospects of serum immunoglobulin free light chain (FLC) determination in chronic inflammatory disease

The development of serum assays for free FLC k and l has opened the door to new applications increasing their clinical importance beyond monoclonal gammopathies and plasma cell dyscrasias. In particular, the availability of these tests may open new prospects for diagnosing and managing various diseases characterized by chronic inflammation, namely autoimmune disease, allergic disease, viral infections, inflammatory disorders of the central nervous system and others. For most of these diseases, serum polyclonal FLC concentrations correlate with disease activity, being a potential useful index for adjusting therapeutic regimens. The aim of this review is to summarize current available data from the literature and to analyze the possible role of FLC in improving the clinical management of patients with chronic inflammatory disorders.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967